Xenobiotica 1984-12-01

A species difference in the presystemic metabolism of carbazeran in dog and man.

B Kaye, J L Offerman, J L Reid, H L Elliott, W S Hillis

Index: Xenobiotica 14(12) , 935-45, (1984)

Full Text: HTML

Abstract

The bioavailability of carbazeran and the metabolism of carbon-14 labelled drug have been studied in the dog and man following oral administration. The drug was moderately well absorbed in both species, but there was a marked difference in bioavailability and in routes of metabolism. In the dog, systemic bioavailability was approx. 68% and biotransformation involved mainly O-demethylation. In man, bioavailability was not measurable and carbazeran was almost completely cleared via 4-hydroxylation of the phthalazine moiety. Thus the lack of detectable pharmacological effect in man following oral administration of the drug appears to be due to presystemic metabolism by a particularly active pathway not found in the dog.

Related Compounds

  • carbazeran

Related Articles:

Aldehyde oxidase activity in fresh human skin.

2014-12-01

[Drug Metab. Dispos. 42(12) , 2049-57, (2014)]

A novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834.

2015-06-01

[Drug Metab. Dispos. 43 , 908-15, (2015)]

Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: role of phosphodiesterase inhibition.

1989-09-01

[Br. J. Pharmacol. 98 , 291-301, (1999)]

Application of a Micropatterned Cocultured Hepatocyte System To Predict Preclinical and Human-Specific Drug Metabolism.

2016-02-01

[Drug Metab. Dispos. 44 , 172-9, (2016)]

Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.

2012-03-01

[Drug Metab. Dispos. 40(3) , 625-34, (2012)]

More Articles...